Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24473115)

1.

Arylesterase phenotype-specific positive association between arylesterase activity and cholinesterase specific activity in human serum.

Aoki Y, Helzlsouer KJ, Strickland PT.

Int J Environ Res Public Health. 2014 Jan 27;11(2):1422-43. doi: 10.3390/ijerph110201422.

2.

Cholinesterase, arylesterase, and lipoprotein parameters in twins.

Boman H.

Acta Genet Med Gemellol (Roma). 1980;29(4):281-7.

PMID:
7197453
3.

Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk.

Tang WH, Hartiala J, Fan Y, Wu Y, Stewart AF, Erdmann J, Kathiresan S; CARDIoGRAM Consortium, Roberts R, McPherson R, Allayee H, Hazen SL.

Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2803-12. doi: 10.1161/ATVBAHA.112.253930. Epub 2012 Sep 13.

4.

Analysis of the serum paraoxonase/arylesterase polymorphism in a Turkish population.

Karakaya A, Suzen S, Sardas S, Karakaya AE, Vural N.

Pharmacogenetics. 1991 Oct;1(1):58-61.

PMID:
1668963
5.

Interindividual variations in enzymes controlling organophosphate toxicity in man.

Mutch E, Blain PG, Williams FM.

Hum Exp Toxicol. 1992 Mar;11(2):109-16.

PMID:
1349216
6.

Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin.

Ortigoza-Ferado J, Richter RJ, Hornung SK, Motulsky AG, Furlong CE.

Am J Hum Genet. 1984 Mar;36(2):295-305.

7.

Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.

Serhatlioglu S, Gursu MF, Gulcu F, Canatan H, Godekmerdan A.

Cell Biochem Funct. 2003 Dec;21(4):371-5.

PMID:
14624476
8.
10.

Tissue-specific effects of chlorpyrifos on carboxylesterase and cholinesterase activity in adult rats: an in vitro and in vivo comparison.

Chanda SM, Mortensen SR, Moser VC, Padilla S.

Fundam Appl Toxicol. 1997 Aug;38(2):148-57.

PMID:
9299188
11.

Effect of peroxisome proliferating hypolipidemic agents on serum activity levels of arylesterase and cholinesterase in rats and mice.

Butler EG, England PJ, Williams GM.

Res Commun Chem Pathol Pharmacol. 1988 Apr;60(1):125-8.

PMID:
3381006
12.

Distribution profiles of paraoxonase and cholinesterase phenotypes in a Spanish population.

Hernández AF, Gonzalvo MC, Gil F, Rodrigo L, Villanueva E, Pla A.

Chem Biol Interact. 1999 May 14;119-120:201-9.

PMID:
10421454
13.

Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.

Gan KN, Smolen A, Eckerson HW, La Du BN.

Drug Metab Dispos. 1991 Jan-Feb;19(1):100-6.

PMID:
1673382
14.

Assessment of serum paraoxonase and arylesterase activity in patients with endometrial cancer.

Arioz DT, Camuzcuoglu H, Toy H, Kurt S, Celik H, Erel O.

Eur J Gynaecol Oncol. 2009;30(6):679-82.

PMID:
20099504
17.

Characterization of plasma cholinesterase from the White stork (Ciconia ciconia) and its in vitro inhibition by anticholinesterase pesticides.

Oropesa AL, Gravato C, Sánchez S, Soler F.

Ecotoxicol Environ Saf. 2013 Nov;97:131-8. doi: 10.1016/j.ecoenv.2013.07.022. Epub 2013 Aug 17.

PMID:
23962622
18.

[The monitoring of cholinesterases in farm workers and tradesmen exposed to phosphoric esters and carbamates].

Faustini A, Arpaia F, Pagliarella P, Forastiere F, Papini P, Perucci CA.

Med Lav. 1992 Mar-Apr;83(2):135-45. Italian.

PMID:
1630402
20.

The effect of 2-(o-cresyl)-4H-1:3:2-benzodioxaphosphorin-2-oxide on tissue cholinesterase and carboxylesterase activities of the rat.

Jimmerson VR, Shih TM, Maxwell DM, Kaminskis A, Mailman RB.

Fundam Appl Toxicol. 1989 Oct;13(3):568-75.

PMID:
2612789
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk